From: In vitro evaluation of defined oligosaccharide fractions in an equine model of inflammation
 | TNF- α (pg/ml) |  |  | IL-10 (pg/ml) |  |  |
---|---|---|---|---|---|---|
Incubation | Point estimate | Lower bound | Upper bound | Point estimate | Lower bound | Upper bound |
Blank controls | 12.6 | 9.8 | 15.7 | 187.2 | 156.2 | 222.5 |
GOS 0.5% | 19.7 * | 16.5 | 23.3 | 183.1 | 152.8 | 217.7 |
GOS 1.0% | 24.9 * | 21.1 | 29.3 | 184.2 | 153.5 | 219.2 |
GOS 2.0% | 35.5 * # | 30.2 | 41.6 | 179.8 | 149.6 | 214.2 |
GOS/FOS 0.5% | 30.2 * | 25.7 | 35.4 | 185.5 | 154.8 | 221.4 |
GOS/FOS 1.0% | 63.4 * # | 54.1 | 74.2 | 190.2 | 160.0 | 225.7 |
GOS/FOS 2.0% | 127.5 * # | 108.6 | 149.5 | 186.0 | 154.5 | 221.4 |
GOS/FOS/AOS 0.5% | 73.6 * | 62.9 | 86.4 | 205.2 | 173.8 | 242.5 |
GOS/FOS/AOS 1.0% | 133.5 * # | 113.7 | 156.6 | 214.2 | 181.6 | 252.4 |
GOS/FOS/AOS 2.0% | 61.4 * # | 52.4 | 72.2 | 186.8 | 157.3 | 221.0 |